HOME >> MEDICINE >> NEWS
NIH scientists target future pandemic strains of H5N1 avian influenza

Preparing vaccines and therapeutics that target a future mutant strain of H5N1 influenza virus sounds like science fiction, but it may be possible, according to a team of scientists at the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and a collaborator at Emory University School of Medicine. Success hinges on anticipating and predicting the crucial mutations that would help the virus spread easily from person to person.

Led by Gary Nabel, M.D., Ph.D., director of the NIAIDs Dale and Betty Bumpers Vaccine Research Center (VRC), the team is reporting in the August 10, 2007 issue of the journal Science that they have developed a strategy to generate vaccines and therapeutic antibodies that could target predicted H5N1 mutants before these viruses evolve naturally. This advance was made possible by creating mutations in the region of the H5N1 hemagglutinin (HA) protein that directs the virus to bird or human cells and eliciting antibodies to it.

What Dr. Nabel and his colleagues have discovered will help to prepare for a future threat, says NIH Director Elias A. Zerhouni, M.D. While nobody knows if and when H5N1 will jump from birds to humans, they have come up with a way to anticipate how that jump might occur and ways to respond to it.

Now we can begin, preemptively, to consider the design of potential new vaccines and therapeutic antibodies to treat people who may someday be infected with future emerging avian influenza virus mutants, says NIAID Director Anthony S. Fauci, M.D. This research could possibly help to contain a pandemic early on.

Making a vaccine against an existing strain of H5N1 or any other type of influenza virus is relatively routine. Typically, samples of existing influenza virus strains are isolated and then grown inside eggs or in cell cultures. The virus is then collected, inactivated, purified and added to the other components o
'"/>

Contact: Jason Socrates Bardi
jbardi@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
9-Aug-2007


Page: 1 2 3

Related medicine news :

1. Barrow scientists make headlines for their research on fixational eye movements
2. UD scientists invent novel hydrogels for repairing, regenerating human tissue
3. UK scientists set their sights on cure for AMD
4. Fat protein cuts blood vessel inflammation, may help heart, Jefferson scientists find
5. Smart mice teach scientists about learning process, brain disorders
6. Why predicting the next influenza pandemic is difficult and how scientists can best prepare
7. Sex and prenatal hormone exposure affect cognitive performance, Yerkes scientists find
8. AACR awards minority and other underrepresented scientists
9. Jefferson scientists find that plavix appears to be safe during and after heart bypass
10. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes
11. Forsyth scientists wiping out tooth decay through school-based cavities prevention program

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH scientists target future pandemic strains avian influenza

(Date:7/28/2015)... ... July 29, 2015 , ... Meet a Millionaire, ... A-Listers, has evolved into a world class millionaires club, according to the site’s ... successful and attractive people seeking real, meaningful and mutually beneficial relationships and provide ...
(Date:7/28/2015)... ... ... Talking About Your Product Pipeline:, How FDA and SEC Regulate Life Sciences ... http://www.fdanews.com/productpipeline , When a company has a product in development, whether drug, device ... regulated by the FDA. , At the same time, the SEC requires that information ...
(Date:7/28/2015)... ... July 29, 2015 , ... ... as a 2015-2016 inductee into its VIP Woman of the Year Circle. ... the nation's leading networking organization exclusively for professional women, boasting more than 700,000 ...
(Date:7/28/2015)... ... July 29, 2015 , ... City Sports, a specialty sports retailer and a ... Marty Hanaka as CEO. , Hanaka, who has served on the Board of Directors ... at the Highland Consumer Fund has had previous tenures as Chairman and CEO of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Every July, since 2007, ... the disease only experience through movies and television. They go to summer camp. , ... right side of the heart as it pushes hard to get blood through arteries ...
Breaking Medicine News(10 mins):Health News:Meet a Millionaire Announces It’s Not a Sugar Daddy Site, It’s a True Millionaires Club 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:National Association of Professional Women Inducts Susan Bentley, Owner of Women's Wellness Options, Into its VIP Woman of the Year Circle 2Health News:City Sports Names Marty Hanaka CEO 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3
(Date:7/28/2015)... 28, 2015 Codman Neuro*, part of DePuy ... new platform of embolic coils for the treatment of ... to improve microcatheter stability and provide an optimized detachment ... here at the Society of NeuroInterventional Surgery (SNIS) 12 ... framing, filling and finishing coils used during a minimally ...
(Date:7/28/2015)... Calif. , July 28, 2015 Amgen ... Directors today declared a $0.79 per share dividend for ... paid on Sept. 8, 2015, to all stockholders of ... 17, 2015.  About Amgen Amgen is ... suffering from serious illnesses by discovering, developing, manufacturing and ...
(Date:7/28/2015)... -- Insulet Corporation (NASDAQ: PODD ), the leader in ... Insulin Management System, today announced that Dr. Jessica ... Directors. Dr. Hopfield brings more than two ... She currently serves as the Vice Chair of the ... diabetes research center, diabetes clinic, and provider of diabetes ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3
Cached News: